Comment on "Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics"
Clin Proteomics
.
2023 Oct 25;20(1):46.
doi: 10.1186/s12014-023-09433-w.
Authors
Fereshteh Behdarvand Dehkordi
1
2
,
Mohammad Chehelgerdi
3
4
Affiliations
1
Novin Genome (NG) Lab, Research and Development Center for Biotechnology, Shahrekord, Iran.
2
Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
3
Novin Genome (NG) Lab, Research and Development Center for Biotechnology, Shahrekord, Iran. Chehelgerdi1992@gmail.com.
4
Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran. Chehelgerdi1992@gmail.com.
PMID:
37880604
PMCID:
PMC10598925
DOI:
10.1186/s12014-023-09433-w
No abstract available
Publication types
Letter